Company's annual revenue growth of 647.84% outperformed its 3 year CAGR of 113.73%. (Source: Standalone Financials)
Employee & Interest Expense
Company has spent 11.51% of its operating revenues towards interest expenses and 14.9% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)
OneSource Specialty Share Price Update
OneSource Specialty Pharma Ltd. share price moved down by -0.03% from its previous close of Rs 1,847.00. OneSource Specialty Pharma Ltd. stock last traded price is 1,846.60
Share Price
Value
Today/Current/Last
1,846.601,844.00
Previous Day
1,847.001,848.65
InsightsOneSource Specialty
Do you find these insights useful?
hate it
meh
love it
Key Metrics
PE Ratio
(x)
-1,676.23
EPS - TTM
(₹)
-1.10
Dividend Yield
(%)
0.00
VWAP
(₹)
1,849.17
PB Ratio
(x)
3.60
MCap
(₹ Cr.)
21,137.30
Face Value
(₹)
1.00
BV/Share
(₹)
513.74
Sectoral MCap Rank
28
52W H/L
(₹)
2,248.00 / 1,209.95
Beta
Beta
1 Month
-
3 Months
-
6 Months
-
1 Year
-
3 Years
-
-
MCap/Sales
13.84
PE Ratio
(x)
-1,673.87
EPS - TTM
(₹)
-1.10
Dividend Yield
(%)
0.00
VWAP
(₹)
1,846.07
PB Ratio
(x)
3.60
MCap
(₹ Cr.)
21,107.53
Face Value
(₹)
1.00
BV/Share
(₹)
513.74
Sectoral MCap Rank
28
52W H/L
(₹)
2,249.65 / 1,163.05
Beta
Beta
1 Month
-
3 Months
-
6 Months
-
1 Year
-
3 Years
-
-
MCap/Sales
13.84
OneSource Specialty Share Price Returns
1 Day
-0.03%
1 Week
-2.29%
1 Month
0.32%
3 Months
-6.44%
1 Year
N.A.
3 Years
N.A.
5 Years
N.A.
1 Day
-0.25%
1 Week
-2.29%
1 Month
0.22%
3 Months
-6.62%
1 Year
N.A.
3 Years
N.A.
5 Years
N.A.
ET Stock ScreenersTop Score Companies
Check whether OneSource Specialty belongs to analysts' top-rated companies list?
Company's annual revenue growth of 647.84% outperformed its 3 year CAGR of 113.73%. (Source: Standalone Financials)
Employee & Interest Expense
Company has spent 11.51% of its operating revenues towards interest expenses and 14.9% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)
Company's annual revenue growth of 647.84% outperformed its 3 year CAGR of 113.73%. (Source: Standalone Financials)
Employee & Interest Expense
Company has spent 11.51% of its operating revenues towards interest expenses and 14.9% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)
OneSource Specialty Pharma Ltd., incorporated in the year 2007, is a Small Cap company (having a market cap of Rs 21,137.30 Crore) operating in Pharmaceuticals sector. OneSource Specialty Pharma Ltd. key Products/Revenue Segments include Sale of services and Pharmaceuticals for the year ending 31-Mar-2025.For the quarter ended 30-06-2025, the company has reported a Consolidated Total Income of Rs 332.54 Crore, down 22.46 % from last quarter Total Income of Rs 428.84 Crore and up 12.24 % from last year same quarter Total Income of Rs 296.28 Crore. Company has reported net profit after tax of Rs -.19 Crore in latest quarter.The company’s top management includes Mr.Arun Kumar Pillai, Mr.Neeraj Sharma, Mr.Bharat Shah, Dr.Claudio Albrecht, Mr.Colin Michael Bond, Ms.Debarati Sen, Dr.Rashmi H Barbhaiya, Mr.Vijay Karwal, Mr.Anurag Bhagania, Mr.Biju Mathew, Ms.Allada Trisha. Company has Deloitte Haskins & Sells as its auditors. As on 30-06-2025, the company has a total of 11.45 Crore shares outstanding.OneSource Specialty Share Price Today is Rs. 1846.60. On previous day, the OneSource Specialty Share Price (NSE) closed at Rs. 1839.2, featuring among the most traded securities on the National Stock Exchange.
Shareholdings: As of 30th Jun, 2025, the promoter held 29.79% of the stake in OneSource Specialty shares, out of which 25.01% was pledged. On the same date, foreign institutional investors' (FII) holdings of OneSource Specialty stocks was 18.69% as compared to 18.54% in Mar 2025 with increase of 0.15%. The domestic institutional investors (DII) holdings on 30th Jun, 2025 was 17.96% as compared to 17.9% in Mar 2025 with increase of 0.06%. Out of the total DII holdings in OneSource Specialty shares 9.06% was held by mutual funds. The rest including public held is 33.56%. OneSource Specialty stock price is reflected on both the exchanges - BSE and NSE.
Dividend, Bonus & Split Information: OneSource Specialty Dividend: Ever since 2007, OneSource Specialty dividends has been paid out around 0 times. As on 16 Oct, 2025, 03:46 PM IST, The overall dividend yield for OneSource Specialty stands at 0.0%. The last dividend paid was on null (Rs. null). The Earnings Per Share (EPS) for quarter ending 30th Jun 2025 is Rs. -1.1.
OneSource Specialty Bonus: The most recent bonus issue had been in year null around 0 years ago at 0 : 0 ratio. The first bonus issue was announced in null.
Stock Forecast: After showing 332.54 Cr. of sales and 0.0% of quarterly net null, there have been multiple ups and downs in the OneSource Specialty stock prices in the past few weeks. For example, OneSource Specialty stock price on 8th of October 2025 was around Rs. 1861.8. OneSource Specialty share price now stands at an average of Rs. 1846.60. Judging by last week's performance, stock is in down trend.
OneSource Specialty has a median target price of Rs. 2480.25 in 12 months by 4 analysts. They have provided a high estimate of Rs. 2529.0 and low estimate of Rs. 2417.0 for OneSource Specialty share.
Historical Prices and Performance: OneSource Specialty, incorporated in 2007 is a Mid Cap company (with a market cap of Rs. 21141.87) operating in Pharmaceuticals sector. The Return of Equity (ROE) in last five financial years given by OneSource Specialty stock was -0.3%, -98.85%, -101.83%, -22.83% and 0.0% respectively. The OneSource Specialty share gave a 3 year return of 0.0% as compared to Nifty 50 which gave a return of 0.0%. OneSource Specialty announced 0.0% final dividend on null.
Key Metrics: PE Ratio of OneSource Specialty is -1676.6 Prices/Sales Ratio of OneSource Specialty is 13.84 Price/Book Ratio of OneSource Specialty is 3.6
Peer Insights: Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. For OneSource Specialty, major competitors and peers include Emcure Pharmaceuticals Ltd., Syngene Int., Wockhardt and Eris Lifesciences. As of Mar 2025, the dividend yield of OneSource Specialty stands at 0.0% while Emcure Pharmaceuticals Ltd., Syngene Int., Wockhardt and Eris Lifesciences stand at 0.22%, 0.2%, 0.0% and 0.46% respectively. The PE ratio and PB Ratio of the company are among its competitors stand at -1676.6 and 3.6 respectively.
Leadership of OneSource Specialty : Allada Trisha is Co. Secretary & Compl. Officer Anurag Bhagania is Chief Financial Officer Biju Mathew is Chief Operating Officer Jeffrey Wong is Chief Business Officer Bernhard Thurnbauer is Chief Quality Officer Arun Kumar Pillai is Chairperson & Non Executive Director Neeraj Sharma is Managing Director & CEO Debarati Sen is Ind. Non-Executive Director Colin Michael Bond is Ind. Non-Executive Director Bharat Shah is Non Executive Director Vijay Karwal is Ind. Non-Executive Director Claudio Albrecht is Ind. Non-Executive Director Rashmi H Barbhaiya is Ind. Non-Executive Director
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.